A Research Study for Patients With Metastatic Renal Cell Carcinoma
Status:
Completed
Trial end date:
2004-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the activity of FK228 in metastatic renal cell
carcinoma (RCC) patients who have developed progressive disease (PD) following or during
treatment with immunotherapy.